We're taking on cancer.

Join the movement.

Watch video

reflexion x1. the time is now.

Be among the first to join the journey to BgRT.

Learn More

reflexion machine

Turning cancer on
itself > Finally

RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.

Real-Time Guidance

Cancer is talking.
We’re listening.

When PET radiotracers are introduced into the body, cancer absorbs them and acts as a biological beacon, which our machine can use to track and treat cancer in real time.

Learn More About Emissions

Targeting Cancer

Good news for organs. Bad news for tumors.

Our technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.

Learn About Targeting

Metastatic Disease

A world where stage is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session. 

Discover the Potential

Combination Treatment

Come at cancer from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.

Learn About Treatment

Learn more about RefleXion

RefleXion BGRT

By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.

Clinicians

Discover RefleXion Therapy.

Cancer Centers

See how RefleXion Therapy can play a role
in your cancer program.

Make every day count

See Available Positions

Latest

Press Releases

Lantheus and RefleXion Announce Development and Commercialization Collaboration with the Potential to Improve Future Prostate Cancer Treatment

NORTH BILLERICA, MA, and HAYWARD, CA, September 13, 2021 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus) and RefleXion Medical, Inc., today announced a development and commercialization collaboration to evaluate the use of piflufolastat F 18, Lantheus’ prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) imaging agent, to enable real-time therapeutic guidance of biology-guided radiotherapy1 (BgRT) […]

View All Press chevron right

News

applied radiation oncology logo

Stanford Treats First Patient on RefleXion X1

Physicians at Stanford Radiation Oncology have treated the first patient using the RefleXion X1 system. The RefleXion X1 combines high quality computed tomography (CT) imaging, known as fan-beam CT, with a linear accelerator to reduce motion artifacts that can inhibit accurate targeting of the radiation dose to a patient's tumor. According to the company, its design rotates up to 60 times faster than other linear accelerators and modulates dose delivery from 100 points per beam station.

View All News chevron right

Blog

aapm abstracts

Presentations at AAPM 2021 Further Validate the RefleXion X1 Machine

RefleXion participated in the American Association of Physicists in Medicine (AAPM) 2021 Annual Meeting. In collaboration with its clinical and academic partners, RefleXion presented 13 abstracts focused on the validation and performance of the X1 radiotherapy system. This post includes several of the highlights. The RefleXion™ X1 machine is a novel ring-gantry-based radiotherapy machine that […]

View All Blog Posts chevron right

Feedback
and
Inquiries.

Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up